This is a preview of subscription content, log in via an institution to check access.
Reference
Kostev K, et al. Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany. International Journal of Clinical Pharmacology and Therapeutics : 14 Oct 2013. Available from: URL: http://dx.doi.org/10.5414/CP201969
Rights and permissions
About this article
Cite this article
Switch to rebate tamoxifen affects compliance. PharmacoEcon Outcomes News 693, 9 (2013). https://doi.org/10.1007/s40274-013-0943-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0943-z